International team of CRG, Harvard, Yale, MIT, CSHL and Johns Hopkins publish personalised epigenomes of four individuals in Cell
New mechanism found which can be exploited to prevent or heal damage to the heart
Atlas of circadian and circannual variation reveals therapeutic targets which could benefit from different doses depending on time of day and season
Microexons constitute new potential therapeutic targets for treating diabetes
Study showcases synthetic biology's potential in transforming treatment of human disease
RNA splicing regulation influences transcription of genes inked to type-1 and type-1 diabetes risk
The enzyme’s activity was found to be compromised in human cancer cells
Studying noncoding RNAs opens new avenues to understand human disease
The findings pave the way for the development of routine medical tests that predict the onset of the disease before symptoms appear
New genome imaging technique is “like upgrading from the Hubble to the James Webb”
Contact:
Omar Jamshed
Senior Press & Communications Officer Phone +34 93 316 02 37